{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:53:13Z","timestamp":1793303593668,"version":"4.5.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MP22\/00092; PI21\/00017; PI24\/00010"],"award-info":[{"award-number":["MP22\/00092; PI21\/00017; PI24\/00010"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,4,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              A growing number of novel antipseudomonal \u03b2-lactams have been introduced in recent years, but the emergence of resistance is still a major concern in the treatment of\n              <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n              infections. Here, we compared the mutant prevention concentrations (MPCs) and the nature of first-step resistant mutants to classical and novel \u03b2-lactams in\n              <jats:italic>P. aeruginosa<\/jats:italic>\n              . MPCs were determined in duplicate experiments for ceftazidime, ceftazidime\/avibactam, ceftolozane\/tazobactam, imipenem, imipenem\/relebactam, meropenem, meropenem\/vaborbactam, aztreonam, aztreonam\/avibactam, and cefiderocol in PAO1, PAOMS (\u0394\n              <jats:italic>mutS<\/jats:italic>\n              ), and three extensively drug-resistant (XDR) clinical strains belonging to high-risk clones ST111, ST175, and ST235. Four mutants per strain and antibiotic, obtained from the highest concentration showing growth, were characterized through the determination of the susceptibility profiles and whole genome sequencing. Imipenem\/relebactam presented the lowest MPC values, followed by ceftolozane\/tazobactam. Overall, the MICs of the mutants were consistent with the antibiotic selection concentration, except for cefiderocol, which were much lower. MPCs were lower for ceftazidime\/avibactam and imipenem\/relebactam than those of the corresponding \u03b2-lactam alone. In contrast, MPCs of meropenem \u00b1 vaborbactam and aztreonam \u00b1 avibactam were identical in most strains. Ceftolozane\/tazobactam and ceftazidime\/avibactam derivatives presented mutations in\n              <jats:italic>ampC<\/jats:italic>\n              ,\n              <jats:italic>galU<\/jats:italic>\n              ,\n              <jats:italic>cpxRS,<\/jats:italic>\n              and\/or in\n              <jats:italic>\n                bla\n                <jats:sub>OXA-2<\/jats:sub>\n              <\/jats:italic>\n              when present in the parent strain (ST235). Cefiderocol mutants were mainly defective in iron-uptake systems, particularly PiuA\/DC. All carbapenems had oprD as the first-step mechanism. Imipenem\/relebactam, meropenem \u00b1 vaborbactam, and aztreonam \u00b1 avibactam selected mutations frequently included efflux pumps and regulators. Imipenem \u00b1 relebactam also selected\n              <jats:italic>aroB<\/jats:italic>\n              mutations. This work first describes the MPCs and first-step resistance mechanisms for classical and novel \u03b2-lactams in\n              <jats:italic>P. aeruginosa<\/jats:italic>\n              . The identified shared and differential resistance development patterns between the available classical and novel \u03b2-lactams should be helpful to guide treatment strategies for XDR\n              <jats:italic>P. aeruginosa<\/jats:italic>\n              infections.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/aac.01942-24","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:03:56Z","timestamp":1741698236000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":14,"title":["Mutant prevention concentrations and phenotypic and genomic profiling of first-step resistance mechanisms to classical and novel \u03b2-lactams in\n            <i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1128","volume":"69","author":[{"given":"Miquel \u00c0ngel","family":"Sastre-Femenia","sequence":"first","affiliation":[{"name":"Department of Microbiology, Hospital Universitari Son Espases, Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa), CIBERINFEC","place":["Palma, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonia","family":"Gomis-Font","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital Universitari Son Espases, Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa), CIBERINFEC","place":["Palma, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9327-1894","authenticated-orcid":true,"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Hospital Universitari Son Espases, Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa), CIBERINFEC","place":["Palma, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-19"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2015.995640"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_4_5_2","volume-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. 2024. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization, Geneva."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00685"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2015.08.002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106196"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.09.001"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx424"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac097"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02462-13"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa206"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab496"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad172"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001878"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01363-23"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01147-08"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg269"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.975-983.2006"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.4161\/fly.19695"},{"key":"e_1_3_4_25_2","unstructured":"R Core Team. 2023. R: a language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. Available from: https:\/\/www.R-project.org\/"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.12.026"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/bies.950190814"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv004"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa396"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01117-17"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-024-00591-y"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab213"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1810004115"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005932"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106887"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1039\/b100399m"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00257-10"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00035-09"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01192-23"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.12.021"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01942-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01942-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:38:19Z","timestamp":1743745099000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01942-24"}},"subtitle":[],"editor":[{"given":"Alessandra","family":"Carattoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,2]]}},"alternative-id":["10.1128\/aac.01942-24"],"URL":"https:\/\/doi.org\/10.1128\/aac.01942-24","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"2024-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01942-24"}}